EIR GlaxoSmithKline Jun 2007

Thomas Berry FDA, Burnell Henry FDA$595.00 - Available Now

FDA investigators audited the GlaxoSmithKline - Zebulon, NC, United States facility and issued inspectional observation (via FDA 483) on 12 Jun 2007.

Product details

  • Category:
  • Inspection end: 12 Jun 2007
  • Location: Zebulon, United States
  • FEI: 1033964
Add To Cart